Source comparison
Dosing Frameworks: Appetite Stimulation vs Growth Hormone Focus
MK-677 serves two distinct research pathways, and optimal dosing differs by objective. For appetite stimulation alone. Addressing cachexia models, underfeeding recovery, or anabolic surplus support. 12.5mg daily is the threshold dose. At this level, ghrelin re
This comparison does not assign a generated winner or score.
- MK-677 serves two distinct research pathways, and optimal dosing differs by objective. For appetite stimulation alone. Addressing cachexia models, underfeeding recovery, or anabolic surplus support. 12.5mg daily is the threshold dose. At this level, ghrelin receptor occupancy reaches approximately 60–70%, sufficient to trigger hypothalamic hunger signaling without saturating receptors. Researchers targeting maximum GH output use 25mg daily, which achieves near-complete receptor saturation and produces peak serum GH levels comparable to low-dose exogenous GH administration.
- The critical distinction: appetite response plateaus around 15–20mg, but GH response continues scaling to 25mg. A 2022 comparative trial in Endocrine Research measured ghrelin AUC (area under curve) at 10mg, 20mg, and 30mg doses. The 20mg and 30mg groups showed statistically identical ghrelin elevation, but the 30mg cohort reported 40% higher incidence of transient hyperglycemia. This suggests 25mg represents the functional ceiling for most applications.
- Timing matters as critically as dose. MK-677 has a half-life of approximately 24 hours, meaning once-daily dosing maintains stable plasma levels. Administering the dose in the evening (60–90 minutes before sleep) aligns peak ghrelin release with the body's natural nocturnal GH pulse, which typically occurs 90–120 minutes after sleep onset. Evening dosing also concentrates appetite stimulation to the following morning and early afternoon. Useful for researchers modeling meal-timing interventions. Our experience shows morning dosing produces more diffuse appetite effects throughout the day, which may or may not align with protocol needs.